Welcome
Pharmaceutical & Life Sciences News

Stop Opioid Approvals Until System Is Fixed, FDA Adviser Says (1)

March 21, 2019, 4:58 PMUpdated: March 21, 2019, 8:35 PM

The FDA must stop approving new opioid drugs now and improve its flawed regulatory processes, the chairman of an agency drug advisory committee says.

The agency is green-lighting painkillers without enough evidence that they’re safe or in some cases even necessary, the committee’s chairman, Raeford Brown, said in an interview. And despite being handed a list of recommendations from the National Academies of Sciences, Engineering, and Medicine in 2017 on how to improve opioid approval regulations, “there’s no interest in implementing them,” Brown said.

The FDA didn’t respond to questions or a request for comment March 21.

The National Academies’...

To read the full article log in. To learn more about a subscription click here.